Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥30.8bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥53.3bn2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥24.6bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥3.0bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥2.3bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥2.8bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥5.9bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥2.3bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥1.7bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.5bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.4bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥1.8bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥4.1bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥1.6bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥94.3bnat 2024-09-30Cons.Assets IFRS
Total assets¥85.8bnat 2024-03-31Cons.Assets IFRS
Total assets¥72.5bnat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥66.1bnat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥58.7bnat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥28.1bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥27.0bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥25.0bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥23.9bnat 2023-03-31dCons.Equity IFRS
Equity (owners)¥22.7bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥21.7bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥20.1bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥27.5bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥27.3bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥22.9bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥20.1bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥2.5bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥9.0bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥2.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥460m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥1.9bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥654m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥1.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥148m2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥996m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥42.562024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥88.352023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥35.282023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥42.442024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥88.032023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥35.162023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio24.1%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio25.4%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio27.7%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥241m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥241m
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue2024-04-01 → 2024-09-30¥4.5bn
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue external2024-04-01 → 2024-09-30¥4.4bn
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥139m
jpcrp040300-q2r_E05463-000Application Servicereportable segmentsegment profit2024-04-01 → 2024-09-30¥159m
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue2024-04-01 → 2024-09-30¥22.1bn
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue external2024-04-01 → 2024-09-30¥22.0bn
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥102m
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentsegment profit2024-04-01 → 2024-09-30¥2.6bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥4.4bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥4.4bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥305m
—segment totalrevenue2024-04-01 → 2024-09-30¥31.1bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥30.8bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥241m
—segment totalsegment profit2024-04-01 → 2024-09-30¥3.0bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥218m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥218m
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue2023-04-01 → 2023-09-30¥4.0bn
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue external2023-04-01 → 2023-09-30¥3.9bn
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E05463-000Application Servicereportable segmentsegment profit2023-04-01 → 2023-09-30¥86m
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue2023-04-01 → 2023-09-30¥16.5bn
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue external2023-04-01 → 2023-09-30¥16.4bn
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥95m
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.7bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥4.4bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥4.4bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥498m
—segment totalrevenue2023-04-01 → 2023-09-30¥24.8bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥24.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥218m
—segment totalsegment profit2023-04-01 → 2023-09-30¥2.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 809
ItemContextValueUnit
Net cash provided by used in operating activities IFRSPrior1YTDDuration2441711000JPY
Net cash provided by used in operating activities IFRSCurrentYTDDuration2474317000JPY
Purchase of property plant and equipment inv cf IFRSPrior1YTDDuration-364242000JPY
Purchase of property plant and equipment inv cf IFRSCurrentYTDDuration-306717000JPY
Purchase of intangible assets inv cf IFRSPrior1YTDDuration-46355000JPY
Purchase of intangible assets inv cf IFRSCurrentYTDDuration-62531000JPY
Purchase of investments inv cf IFRSPrior1YTDDuration-328886000JPY
Purchase of investments inv cf IFRSCurrentYTDDuration-112120000JPY
Proceeds from sales of investments inv cf IFRSPrior1YTDDuration97000000JPY
Proceeds from sales of investments inv cf IFRSCurrentYTDDuration0JPY
Payments for leasehold deposits and guarantee deposits inv cf IFRSPrior1YTDDuration-20924000JPY
Payments for leasehold deposits and guarantee deposits inv cf IFRSCurrentYTDDuration-2920000JPY
Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRSPrior1YTDDuration201881000JPY
Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRSCurrentYTDDuration1089000JPY
Payments for asset retirement obligations inv cf IFRSPrior1YTDDuration-199545000JPY
Payments for asset retirement obligations inv cf IFRSCurrentYTDDuration-JPY
Payments of long term loans receivable inv cf IFRSPrior1YTDDuration-JPY
Payments of long term loans receivable inv cf IFRSCurrentYTDDuration-20000000JPY
Other inv cf IFRSPrior1YTDDuration6990000JPY
Other inv cf IFRSCurrentYTDDuration43055000JPY
Net cash provided by used in investing activities IFRSPrior1YTDDuration-654082000JPY
Net cash provided by used in investing activities IFRSCurrentYTDDuration-460144000JPY
Net increase decrease in short term borrowings fin cf IFRSPrior1YTDDuration-JPY
Net increase decrease in short term borrowings fin cf IFRSCurrentYTDDuration-160000000JPY
Repayments of long term borrowings fin cf IFRSPrior1YTDDuration-100000000JPY
Repayments of long term borrowings fin cf IFRSCurrentYTDDuration-100000000JPY
Proceeds from other financial liabilities fin cf IFRSPrior1YTDDuration2451000000JPY
Proceeds from other financial liabilities fin cf IFRSCurrentYTDDuration260502000JPY
Payments of other financial liabilities fin cf IFRSPrior1YTDDuration-313898000JPY
Payments of other financial liabilities fin cf IFRSCurrentYTDDuration-611104000JPY
Dividends paid fin cf IFRSPrior1YTDDuration-637591000JPY
Dividends paid fin cf IFRSCurrentYTDDuration-761320000JPY
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-399832000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-378970000JPY
Other fin cf IFRSPrior1YTDDuration-3221000JPY
Other fin cf IFRSCurrentYTDDuration-6738000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration996454000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-1757632000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration25207000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration596000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration2809290000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration257137000JPY
Cash and cash equivalents IFRSPrior2YearInstant20071540000JPY
Cash and cash equivalents IFRSPrior1YearInstant27265398000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant22880831000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant27522536000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember16370874000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember3873132000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember4358644000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReportableSegmentsMember24602651000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass